SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 8, 2002
DIACRIN, Inc.
--------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 000-2139 22-3016912
------------------------------- ------------------------ -------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
Building 96, 13th Street
Charlestown Navy Yard
Charlestown, MA 02129
------------------------------------- -----------------------------------
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code: (617) 242-9100
N/A
-----------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
----------------------------------------------
(a) On July 8, 2002, Diacrin, Inc. (the "Company") dismissed
Arthur Andersen LLP ("AA") as the Company's independent accountants.
The dismissal of AA was approved by the Audit Committee of the Board of
Directors. The reports of AA on the Company's financial statements for
fiscal years 2001 and 2000 did not contain any adverse opinions or
disclaimers of opinion and were not qualified or modified as to uncertainty,
audit scope or accounting principles. During fiscal years 2001 and 2000 and
through July 8, 2002, there were no disagreements between the Company and
AA on any matters of accounting principles or practices, financial statement
disclosure, or auditing scope or procedures, which disagreements, if not
resolved to the satisfaction of AA, would have caused AA to make reference
to the subject matter of the disagreements in connection with its report on
the Company's financial statements for such years, nor were there any
reportable events pursuant to Item 304(a)(1)(v).
The Company has requested that AA furnish it with a letter addressed to
the Securities and Exchange Commission stating whether or not AA agrees with the
above statements. The Company was not able to obtain a letter after reasonable
efforts and, in accordance with Item 304T, is filing this Form 8-K without a
letter.
(b) On July 8, 2002, the Company engaged PricewaterhouseCoopers LLP
("PWC") as its independent certifying accountants for the fiscal year ending
December 31, 2002. The appointment of PWC was approved by the Audit Committee
of the Board of Directors.
During fiscal years 2001 and 2000 and through July 8, 2002, the
Company did not consult with PWC regarding the application of accounting
principles to a specified transaction, either completed or proposed, the type of
audit opinion that might be rendered on the Company's consolidated financial
statements, or any matter that was the subject of a disagreement with AA or
reportable event pursuant to Item 304(a)(1)(v) of Regulation S-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: July 11, 2002 DIACRIN, Inc.
By: /s/ Kevin Kerrigan
-----------------------------------
Kevin Kerrigan
Controller